Communiqués BioNxt Solutions Inc.

Actions

BNXT

CA0909741062

Marché Fermé - Canadian Securities Exchange Autres places de cotation 17:54:05 15/07/2024			Varia. 5j.	Varia. 1 janv.
0,305 ^CAD	0,00 %		+19,61 %	-37,11 %

29/05	BioNxt Solutions Inc. présente ses résultats pour le premier trimestre terminé le 31 mars 2024	CI
26/04	BioNxt Solutions Inc. annonce une mise à jour sur la Cladribine ODF	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

BioNxt Solutions Inc.	15/07	AQ
BioNxt Solutions Finalizes Agreement	19/02	AQ
CSE Bulletin: Name and Symbol Change - XPhyto Therapeutics Corp. (XPHY)	10/11/22	NE
XPhyto Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placement	04/08/22	AQ
XPhyto Therapeutics : Statement of Executive Compensation for financial year ended December 31, 2021	23/07/22	PU
XPhyto Therapeutics Corp.: XPhyto Pursues Potential Application of its Oral Dissolvable Biosensor Inflammation Test for Buprenorphine-related Dental Disease	18/07/22	EQ
XPhyto Therapeutics Corp. - Prof. Dr. Raimar Loebenberg receives Leadership Award from the Canadian Society for Pharmaceutical Sciences	28/06/22	AQ
XPhyto Therapeutics : Management's Discussion and Analysis for the First Quarter Ended March 31, 2022	01/06/22	PU
XPhyto Therapeutics : Interim Financial Statements for the First Quarter Ended March 31, 2022	01/06/22	PU
XPhyto Therapeutics : Reports Market and Product Developments on Platform-based Rotigotine Transdermal Patch for Parkinson's Disease	04/04/22	PU
XPhyto Therapeutics : Closes First Tranche of Financing	01/04/22	PU
XPhyto Therapeutics Corp.	22/02/22	AQ
XPhyto Therapeutics Reports on its Three Primary Business Divisions	09/02/22	AQ
XPhyto Executes Covid-ID Lab Sales Contracts with Test Clinics and Pharmacies in Germany as part of Multi-Product Rollout Strategy	02/02/22	AQ
XPhyto Therapeutics Corp.	01/02/22	AQ
XPhyto Therapeutics Corp.	24/01/22	AQ
XPhyto Therapeutics Corp.	17/01/22	AQ
XPhyto Therapeutics Corp.	10/01/22	AQ
XPhyto Therapeutics Corp.	15/12/21	AQ
XPhyto Therapeutics Corp.: XPhyto Epilepsy Clinical Trial Planned in 2022 with Its Proprietary Fast-Dissolving CBD Oral Strips	15/12/21	EQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués BioNxt Solutions Inc.

Actions

BNXT

CA0909741062

Communiqués

Filtres